ID   NALM-34
AC   CVCL_5672
SY   NALM34
DR   Wikidata; Q54907416
RX   PubMed=9680106;
RX   PubMed=10609789;
CC   Population: Japanese.
CC   Doubling time: 72 hours (PubMed=10609789).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5671 ! NALM-33
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
RX   PubMed=10609789; DOI=10.1080/10428199909169616;
RA   Matsuo, Yoshinobu
RA   Drexler, Hans Gunther
RA   Takeuchi, Makoto
RA   Orita, Kunzo
RT   "Novel B-cell precursor leukemia sister cell lines, NALM-33 and NALM-34,
RT   established from a patient with acute lymphoblastic leukemia.";
RL   Leuk. Lymphoma 35:513-526(1999).
//
RX   PubMed=9680106; DOI=10.1016/S0145-2126(98)00050-2;
RA   Matsuo, Yoshinobu
RA   Drexler, Hans Gunther
RT   "Establishment and characterization of human B cell precursor-leukemia
RT   cell lines.";
RL   Leuk. Res. 22:567-579(1998).
//